AFREZZA

Peak

insulin human

BLAINHALATIONPOWDER
Approved
Jun 2014
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

fat, and by inhibiting hepatic glucose production. Insulin inhibits lipolysis in adipocytes, inhibits proteolysis, and enhances protein synthesis.

Pharmacologic Class:

Insulin

Indications (1)

glycemic control in adult patients with diabetes mellitus

Clinical Trials (1)

NCT01269606Phase 1Completed

Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

Started Jan 2011
13 enrolled
DiabetesDiabetes Mellitus, Type 1
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers